This article is a correction to:
Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
Ying Chen1,2
Rui Li2Yuqi Zhu2,3Sixia Zhong2Jinjun Qian2Dongqing Yang2Artur Jurczyszyn4Meral Beksac5
Chunyan Gu1,2*
Ye Yang2,6*- 1The Third Affifiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
- 2School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China
- 3Department of Internal Medicine, University of Iowa, Iowa City, IA, United States
- 4Department of Hematology, Collegium Medicum, Jagiellonian University, Kraków, Poland
- 5Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey
- 6Key Laboratory for Combination of Acupuncture and Chinese Materia Medica of Chinese Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, China
A Corrigendum on
Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
By Chen Y, Li R, Zhu Y, Zhong S, Qian J, Yang D, Jurczyszyn A, Beksac M, Gu C and Yang Y (2020). Front. Oncol. 10:767. doi: 10.3389/fonc.2020.00767
In the original article, there was an unsatisfied WB result in Figure 3 as published. Dr. Tulipa Fosteriana pointed that in Figure 3C, the 2 loading controls bared striking resemblance, although they looked somehow different in vertical dimension and the image quality was also quite poor, which were posted on PubPeer. According to the valuable suggestions, we have provided all the original data to Frontiers Office to prove the authenticity. There was no error in the original data, however, based on the recommendation from Editorial Office, we replaced the previous figure with the repeated “C of Figure 3” with high quality. The corrected Figure 3 appears below.
FIGURE 3
Figure 3 DHA induces caspase-mediated apoptosis in MM cell lines. (A–C) The protein levels of caspase-3, PARP, Bcl-2, and Bad were determined by western blotting in MM cells. The results showed that caspase-3 and PARP were increased after 12 h, while Bcl-2 and Bad were decreased after 12 h.
The authors state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: dihydroartemisinin, artemisinin, multiple myeloma, dexamethasone, drug resistance
Citation: Chen Y, Li R, Zhu Y, Zhong S, Qian J, Yang D, Jurczyszyn A, Beksac M, Gu C and Yang Y (2021) Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma. Front. Oncol. 11:736373. doi: 10.3389/fonc.2021.736373
Received: 05 July 2021; Accepted: 09 July 2021;
Published: 23 July 2021.
Edited and reviewed by:
Francesca Vinchi, New York Blood Center, United StatesCopyright © 2021 Chen, Li, Zhu, Zhong, Qian, Yang, Jurczyszyn, Beksac, Gu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chunyan Gu, Z3VjaHVueWFuQG5qdWNtLmVkdS5jbg==; Ye Yang, eWFuZ3llODc2QHNpbmEuY29t